Dyne Therapeutics Inc (DYN)
28.71
-0.07
(-0.24%)
USD |
NASDAQ |
Nov 05, 11:24
Dyne Therapeutics Price to Book Value: 3.718 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 3.728 |
| November 01, 2024 | 3.722 |
| October 31, 2024 | 3.738 |
| October 30, 2024 | 3.782 |
| October 29, 2024 | 3.914 |
| October 28, 2024 | 3.986 |
| October 25, 2024 | 3.980 |
| October 24, 2024 | 4.028 |
| October 23, 2024 | 4.191 |
| October 22, 2024 | 4.325 |
| October 21, 2024 | 4.336 |
| October 18, 2024 | 4.564 |
| October 17, 2024 | 4.498 |
| October 16, 2024 | 4.585 |
| October 15, 2024 | 4.350 |
| October 14, 2024 | 4.314 |
| October 11, 2024 | 4.361 |
| October 10, 2024 | 4.217 |
| October 09, 2024 | 4.147 |
| October 08, 2024 | 4.291 |
| October 07, 2024 | 4.103 |
| October 04, 2024 | 4.220 |
| October 03, 2024 | 4.345 |
| October 02, 2024 | 4.604 |
| October 01, 2024 | 4.502 |
| Date | Value |
|---|---|
| September 30, 2024 | 4.652 |
| September 27, 2024 | 4.382 |
| September 26, 2024 | 4.484 |
| September 25, 2024 | 4.518 |
| September 24, 2024 | 4.326 |
| September 23, 2024 | 4.485 |
| September 20, 2024 | 4.739 |
| September 19, 2024 | 4.716 |
| September 18, 2024 | 4.448 |
| September 17, 2024 | 4.481 |
| September 16, 2024 | 4.455 |
| September 13, 2024 | 4.411 |
| September 12, 2024 | 4.283 |
| September 11, 2024 | 4.222 |
| September 10, 2024 | 4.200 |
| September 09, 2024 | 4.205 |
| September 06, 2024 | 4.278 |
| September 05, 2024 | 4.358 |
| September 04, 2024 | 4.372 |
| September 03, 2024 | 4.137 |
| August 30, 2024 | 5.969 |
| August 29, 2024 | 5.862 |
| August 28, 2024 | 5.830 |
| August 27, 2024 | 5.703 |
| August 26, 2024 | 5.813 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6694
Minimum
Jun 02 2022
26.80
Maximum
Mar 28 2024
3.834
Average
2.566
Median
Jan 06 2023
Price to Book Value Benchmarks
| Sarepta Therapeutics Inc | 10.91 |
| Capricor Therapeutics Inc | 52.48 |
| Regenxbio Inc | 1.259 |
| Catalyst Pharmaceuticals Inc | 4.233 |
| Vertex Pharmaceuticals Inc | 8.584 |
Price to Book Value Related Metrics
| Price | 28.71 |
| Earnings Yield | -12.50% |
| Market Cap | 2.883B |